Skip to main content

Biosyent Inc(RX-X)
TSX Venture

Today's Change
Delayed Last Update

Closing Bell: Biosyent Inc flat on Wednesday (RX)

Automated Summaries - The Globe and Mail - Wed Apr 24, 4:02PM CDT

Today during trading, Biosyent Inc opened at $8.44 and closed at $8.40. prices ranged from a low of $8.40 to a high of $8.61.

Share prices $verbed percentage_change% from the previous day's close of $8.40.

During the day across North America, the TSX Composite closed -0.63% at 21873.72, the S&P 500 closed 1.20% at 5070.55, the Dow Jones Industrial Average closed 0.69% at 38503.69 and the Nasdaq Composite closed 1.59% at 15696.64.

Biosyent Inc traded under RX on the Toronto Venture Exchange (TSX-V).

A total of 65,245 shares was traded during the session, with total trades of 43. On average, Biosyent Inc has traded 15,646 shares over the last 5-days and 5,942 year-to-date.

The TSX-V overall saw 2,208 price advancers against 2,970 declines and 124 unchanged.

During the prior 52 weeks, RX.VN has traded as high as $9.26 (December 29,2023) and low as $7.03 (July 06,2023). Moreover, the shares have advanced 8.39% in the last year, while in 2024, they have eased -8.89%.

It announced a 0.04 dividend on February 07/24, with an February 28/24 ex-date and March 15/24 pay day.

Following today's trading, Biosyent Inc has a market capitalization of $97.52 million on a float of 11,610 shares outstanding. Its annual EPS is $0.53.

Biosyent Inc is a TSX Drug Specialty & Generic company headquartered in Mississauga, CAN.

Biosyent Inc is holding an average recommendation of "Moderate Buy" from 1.00 analysts according to Zacks. Currently, there are 1 buy ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..

More from The Globe